Distinct Patterns of Constitutive Phosphodiesterase Activity in Mouse Sinoatrial Node and Atrial Myocardium

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Hua, Rui ^a   Adamczyk, Andrew ^a   Robbins, Courtney ^a   Ray, Gibanananda ^a   Rose, Robert A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; CALCIUM CHANNEL L TYPE; ISOBUTYLMETHYLXANTHINE; MILRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; ROLIPRAM; SPLEEN EXONUCLEASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART ATRIUM MUSCLE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART VENTRICLE; MALE; MOUSE; NONHUMAN; SINUS NODE;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; HEART ATRIA; MICE; MYOCYTES, CARDIAC; PHOSPHODIESTERASE 3 INHIBITORS; PHOSPHODIESTERASE 4 INHIBITORS; PHOSPHODIESTERASE INHIBITORS; SINOATRIAL NODE; XANTHINES;

EID: 84867544948     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047652     Document Type: Article

References (50)

1. Bender AT, Beavo JA, (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520.
2. Omori K, Kotera J, (2007) Overview of PDEs and their regulation. Circ Res 100: 309-327.
3. Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, et al. (2003) Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 64: 533-546.
4. Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, et al. (2006) Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 99: 816-828.
5. Movsesian MA, (2002) PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes. Basic Res Cardiol 97Suppl 1: I83-I90.
6. Zaccolo M, (2011) Spatial control of cAMP signalling in health and disease. Curr Opin Pharmacol 11: 649-655.
7. Patrucco E, Albergine MS, Santana LF, Beavo JA, (2010) Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes. J Mol Cell Cardiol 49: 330-333.
8. Fischmeister R, Hartzell HC, (1991) Cyclic AMP phosphodiesterases and Ca2+ current regulation in cardiac cells. Life Sci 48: 2365-2376.
9. Mongillo M, Tocchetti CG, Terrin A, Lissandron V, Cheung YF, et al. (2006) Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ Res 98: 226-234.
10. Kerfant BG, Zhao D, Lorenzen-Schmidt I, Wilson LS, Cai S, et al. (2007) PI3K? is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes. Circ Res 101: 400-408.
11. Verde I, Vandecasteele G, Lezoualc'h F, Fischmeister R, (1999) Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Br J Pharmacol 127: 65-74.
12. Lakatta EG, Maltsev VA, Vinogradova TM, (2010) A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 106: 659-673.
13. DiFrancesco D, (1993) Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 55: 455-472.
14. Irisawa H, Brown HF, Giles W, (1993) Cardiac pacemaking in the sinoatrial node. Physiol Rev 73: 197-227.
15. Mangoni ME, Nargeot J, (2008) Genesis and regulation of the heart automaticity. Physiol Rev 88: 919-982.
16. Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, et al. (2003) Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 100: 5543-5548.
17. Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, et al. (2002) Functional Roles of Cav1.3 (a1D) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 90: 981-987.
18. Nerbonne JM, Kass RS, (2005) Molecular physiology of cardiac repolarization. Physiol Rev 85: 1205-1253.
19. Zhang Z, He Y, Tuteja D, Xu D, Timofeyev V, et al. (2005) Functional roles of Cav1.3 (a1D) calcium channels in atria: insights gained from gene-targeted null mutant mice. Circulation 112: 1936-1944.
20. Springer J, Azer J, Hua R, Robbins C, Adamczyk A, et al. (2012) The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. J Mol Cell Cardiol 52: 1122-1134.
21. Cifelli C, Rose RA, Zhang H, Voigtlaender-Bolz J, Bolz SS, et al. (2008) RGS4 Regulates Parasympathetic Signaling and Heart Rate Control in the Sinoatrial Node. Circ Res 103: 527-535.
22. Rose RA, Lomax AE, Kondo CS, Anand-Srivastava MB, Giles WR, (2004) Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. Am J Physiol 286: H1970-H1977.
23. Rose RA, Sellan M, Simpson JA, Izaddoustdar F, Cifelli C, et al. (2011) Iron Overload Decreases CaV1.3-Dependent L-Type Ca2+ Currents Leading to Bradycardia, Altered Electrical Conduction, and Atrial Fibrillation. Circ Arrhythm Electrophysiol 4: 733-742.
24. Marionneau C, Couette B, Liu J, Li H, Mangoni ME, et al. (2005) Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562: 223-234.
25. Mery PF, Pavoine C, Pecker F, Fischmeister R, (1995) Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol Pharmacol 48: 121-130.
26. Lugnier C, (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109: 366-398.
27. Rivet-Bastide M, Vandecasteele G, Hatem S, Verde I, Benardeau A, et al. (1997) cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. J Clin Invest 99: 2710-2718.
28. Vandecasteele G, Verde I, Rucker-Martin C, Donzeau-Gouge P, Fischmeister R, (2001) Cyclic GMP regulation of the L-type Ca2+ channel current in human atrial myocytes. J Physiol 533: 329-340.
29. Bers DM, Perez-Reyes E, (1999) Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 42: 339-360.
30. Marban E, (2002) Cardiac channelopathies. Nature 415: 213-218.
31. Richter W, Xie M, Scheitrum C, Krall J, Movsesian MA, et al. (2011) Conserved expression and functions of PDE4 in rodent and human heart. Basic Res Cardiol 106: 249-262.
32. Beca S, Schars-Sobbi R, Panama BK, Backx PH, (2011) Regulation of murine cardiac function by phosphodiesterases type 3 and 4. Curr Opin Pharmacol 11: 714-719.
33. Kerfant BG, Rose RA, Sun H, Backx PH, (2006) Phosphoinositide 3-kinase? Regulates Cardiac Contractility by Locally Controlling Cyclic Adenosine Monophosphate Levels. Trends Cardiovasc Med 16: 250-256.
34. Vinogradova TM, Sirenko S, Lyashkov AE, Younes A, Li Y, et al. (2008) Constitutive phosphodiesterase activity restricts spontaneous beating rate of cardiac pacemaker cells by suppressing local Ca2+ releases. Circ Res 102: 761-769.
35. Hata T, Nishimura M, Ogino K, Uchiyama H, Watanabe Y, (1998) Electrophysiological effects of amrinone on the automaticity and membrane current system of the rabbit sinoatrial node cells. Heart Vessels 13: 114-121.
36. Orito K, Takase H, Fujiki H, Mori T, (1996) Effects of toborinone (OPC-18790), a new positive inotropic agent, on action potential in guinea pig sinoatrial node: compared with milrinone and E-4031. Jpn J Pharmacol 72: 79-82.
37. Kaumann AJ, (2011) Phosphodiesterases reduce spontaneous sinoatrial beating but not the 'fight or flight' tachycardia elicited by agonists through Gs-protein-coupled receptors. Trends Pharmacol Sci 32: 377-383.
38. Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, et al. (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95: 794-802.
39. Molina CE, Leroy J, Richter W, Xie M, Scheitrum C, et al. (2012) Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. J Am Coll Cardiol 59: 2182-2190.
40. DiFrancesco D, Tromba C, (1988) Muscarinic control of the hyperpolarization-activated current (if) in rabbit sino-atrial node myocytes. J Physiol 405: 493-510.
41. Shimizu K, Shintani Y, Ding WG, Matsuura H, Bamba T, (2002) Potentiation of slow component of delayed rectifier K+ current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G. Br J Pharmacol. 137: 127-137.
42. Clark RB, Mangoni ME, Lueger A, Couette B, Nargeot J, et al. (2004) A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. Am J Physiol Heart Circ Physiol 286: H1757-H1766.
43. Hagiwara N, Irisawa H, Kameyama M, (1988) Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 395: 233-253.
44. Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, et al. (2006) Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/a1G T-type calcium channels. Circ Res 98: 1422-1430.
45. Bean BP, (1985) Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Gen Physiol 86: 1-30.
46. Ertel SI, Ertel EA, Clozel JP, (1997) T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11: 723-739.
47. Hess P, (1988) Elementary properties of cardiac calcium channels: a brief review. Can J Physiol Pharmacol 66: 1218-1223.
48. Hirano Y, Fozzard HA, January CT, (1989) Characteristics of L- and T-type Ca2+ currents in canine cardiac Purkinje cells. Am J Physiol 256: H1478-H1492.
49. Vandeput F, Wolda SL, Krall J, Hambleton R, Uher L, et al. (2007) Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes. J Biol Chem 282: 32749-32757.
50. Zhang M, Kass DA, (2011) Phosphodiesterases and cardiac cGMP: evolving roles and controversies. Trends Pharmacol Sci 32: 360-365.